Ceribell Inc CBLL
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2024-10-11 |
| Shares Out. | 37,940,000 |
| Website | ceribell.com/ ↗ |
| Phone | 18004360826 |
| Employees | 300 |
| Revenue | $26.5M |
| Gross Profit | $23.1M |
| Net Income | -$19.7M |
| Free Cash Flow | -$50.2M |
| Total Assets | $178.1M |
| Total Liabilities | $37.3M |
| Equity | $140.8M |
About Ceribell Inc
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
Ceribell Inc is a publicly traded company under the ticker symbol CBLL on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
14 analysts (2026-07-01)